VEEV Veeva Systems Inc.

Stock NYSE Technology

US$312.94 +0.84% Latest close

Trend channel, buy level and 3-month target. Information only, not financial advice.

Below the channel · 9-month channel rising

Closed below support (US$331.77). Treat the buy level with caution.

9-month channel read from
US$331.77 – US$398.38 · rising, more than +100% a year
12-month channel
US$133.93 – US$312.45 · rising, +10% a year
Price in channel
−28% (0% = floor, 100% = ceiling)
Ceiling overhead
US$398.38
Published levels
Buy and target are not from this channel — see below.

Price history, with the path projected 3 months forward

Updated 5:46 PM ET (66 h ago)

US$100.0US$200.0US$300.0US$400.0Nov 23Apr 24Sept 24Feb 25July 25Dec 25May 26Oct 26 today BuyTarget Our buy US$310.3 · est. 1 Nov 26Our target US$341.4 · est. 4 Dec 26
  • Daily close
  • Upper trend line (9 months)
  • Lower trend line (9 months)
  • The same lines over the last 12 months
  • Dashed after today: projected 3 months
  • Our buy
  • Our target

Suggested path

Buy at or below

US$310.32

level as at 1 Nov 2026

Our target

US$341.35

by 24 Nov 2026

Projected move

10.0%

gross, before costs

Price is between our buy and target.

Target: VEEV's usual move size (10.0%), the best return per day on this path.

This move size: reached in 42% of 21 past stretches, typically in 36 days. (0.28% per day)

Upper line touches
2
Lower line touches
2
Fit confidence
56%
Fitted
1 Nov 2026

Company information

About Veeva Systems Inc.

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operations. This includes vital applications such as Veeva Customer Relationship Management (CRM) and its specialized Medical CRM, Veeva Closed Loop Marketing (CLM), sophisticated analytics via Veeva CRM MyInsights, approved email communication with Veeva CRM Approved Email, digital engagement tools like Veeva CRM Engage, commercial alignment through Veeva Align, event management capabilities with Veeva CRM Events Management, data warehousing solutions (Veeva Nitro), data services (Veeva OpenData, Veeva Link), master data management (Veeva Network), advanced analytical insights (Veeva Crossix, Veeva Data Cloud), and patient engagement platforms (MyVeeva for Patients). Secondly, Veeva Vault provides a robust collection of cloud-native enterprise content and data management applications. These applications are engineered to support both critical commercial functions—encompassing sales, marketing, and medical content and communications—and comprehensive research and development processes, including clinical trials, regulatory compliance, quality management, and patient safety. Beyond its software, Veeva offers a wide array of professional and support services. These range from strategic implementation and deployment planning, project management, and detailed requirements analysis to solution design and configuration. They also include system environment management and deployment, expert consulting for business process transformation related to Veeva solutions, technical guidance on data migration and systems integrations, comprehensive training programs, and ongoing managed services such as outsourced systems administration. Tracing its origins, the company was incorporated in 2007 as Verticals onDemand, Inc., and subsequently rebranded to Veeva Systems Inc. in April 2009. Its corporate headquarters are situated in Pleasanton, California.

Sector
Technology
Industry
Software - Application
CEO
Peter Gassner
Employees
7,928
Country
US

https://www.veeva.com

Scorecard

Our own scores from the fundamentals below (not Morningstar ratings).

Valuation
—
Profitability
—
Financial health
—
Cash generation
—

Key statistics

Market cap
US$44.65B
Enterprise value
—
Beta
0.97
Avg volume
2.15M
Revenue per share
—
Dividend yield
—
52-week range
148.05-310.5
Exchange
NYSE

Key ratios

P/E (TTM)
—
PEG
—
Price / sales
—
Price / book
—
EV / EBITDA
—
Gross margin
—
Operating margin
—
Net margin
—
Current ratio
—
Quick ratio
—
Debt / equity
—
Interest cover
—

Income statement

Balance sheet

Cash flow

Trend lines are fitted to past swing highs and lows and may not continue. Information only, not financial advice.